These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 39081551)

  • 1. A 12-month, longitudinal, intervention study examining a tablet protein substitute preparation in the management of tyrosinemia.
    Daly A; Evans S; Pinto A; Ashmore C; MacDonald A
    Mol Genet Metab Rep; 2024 Sep; 40():101119. PubMed ID: 39081551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I.
    Daly A; Evans S; Pinto A; Ashmore C; MacDonald A
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
    Daly A; Evans S; Chahal S; Santra S; MacDonald A
    J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.
    Daly A; Evans S; Chahal S; Santra S; Pinto A; Jackson R; Gingell C; Rocha J; Van Spronsen FJ; MacDonald A
    Orphanet J Rare Dis; 2019 Feb; 14(1):44. PubMed ID: 30770754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a casein glycomacropeptide-based protein substitute, in the dietary management of NTBC-induced tyrosinaemia in patients with alkaptonuria: A prospective open-label study.
    Judd S; Hutton A; Thomas G; Hill H
    J Hum Nutr Diet; 2024 Dec; 37(6):1496-1504. PubMed ID: 39290064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial.
    Daly A; Evans S; Chahal S; Santra S; Pinto A; Gingell C; Rocha JC; van Spronsen F; Jackson R; MacDonald A
    Nutrients; 2019 Feb; 11(3):. PubMed ID: 30823411
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of a New Glycomacropeptide-Based Protein Substitute in Powdered and Liquid Format in Patients with PKU.
    Delsoglio M; Capener R; MacDonald A; Daly A; Ashmore C; Ellerton C; Donald S; Gaff L; VanDorp L; Skeath R; Newby C; Dunning G; Dale C; Hunjan I; White L; Allen H; Hubbard GP; Stratton RJ
    Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Protein Tolerance and Metabolic Control in Patients with Hereditary Tyrosinaemia Type 1.
    Yilmaz O; Daly A; Pinto A; Ashmore C; Evans S; Gupte G; Santra S; Preece MA; Mckiernan P; Kitchen S; Ayhan NY; MacDonald A
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a New 'Mix-In' Style Glycomacropeptide-Based Protein Substitute for Food and Drinks in Patients with Phenylketonuria and Tyrosinemia.
    Delsoglio M; Capener R; MacDonald A; Daly A; Ashmore C; Donald S; Gaff L; VanDorp L; Skeath R; Ellerton C; Newby C; Dunning G; Dale C; Hunjan I; White L; Allen H; Hubbard GP; Stratton RJ
    Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source.
    Pinto A; Almeida MF; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; MacDonald A; Rocha JC
    Eur J Clin Nutr; 2017 Oct; 71(10):1230-1234. PubMed ID: 28402322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.
    Ahring KK; Dagnæs-Hansen F; Brüel A; Christensen M; Jensen E; Jensen TG; Johannsen M; Johansen KS; Lund AM; Madsen JG; Brøndum-Nielsen K; Pedersen M; Sørensen LK; Kjolby M; Møller LB
    PLoS One; 2022; 17(1):e0261150. PubMed ID: 35015767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria.
    Daly A; Evans S; Pinto A; Jackson R; Ashmore C; Rocha JC; MacDonald A
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study.
    Burlina AP; Cazzorla C; Massa P; Polo G; Loro C; Gueraldi D; Burlina AB
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Three-Year Longitudinal Study Comparing Bone Mass, Density, and Geometry Measured by DXA, pQCT, and Bone Turnover Markers in Children with PKU Taking L-Amino Acid or Glycomacropeptide Protein Substitutes.
    Daly A; Högler W; Crabtree N; Shaw N; Evans S; Pinto A; Jackson R; Ashmore C; Rocha JC; Strauss BJ; Wilcox G; Fraser WD; Tang JCY; MacDonald A
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34204378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fifteen years of using a second stage protein substitute for weaning in phenylketonuria: a retrospective study.
    Evans S; Daly A; MacDonald J; Pinto A; MacDonald A
    J Hum Nutr Diet; 2018 Jun; 31(3):349-356. PubMed ID: 28940742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: A case report.
    Pinto A; Almeida MF; Cunha A; Carmona C; Rocha S; Guimas A; Ribeiro R; Mota CR; Martins E; MacDonald A; Rocha JC
    Mol Genet Metab Rep; 2017 Dec; 13():105-110. PubMed ID: 29085781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
    Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
    Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of paediatric PKU breath malodour, comparing glycomacropeptide with phenylalanine free L-amino acid supplements.
    Tiele A; Daly A; Hattersley J; Pinto A; Evans S; Ashmore C; MacDonald A; Covington JA
    J Breath Res; 2019 Oct; 14(1):016001. PubMed ID: 31476741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment adherence in tyrosinemia type 1 patients.
    González-Lamuño D; Sánchez-Pintos P; Andrade F; Couce ML; Aldámiz-Echevarría L
    Orphanet J Rare Dis; 2021 Jun; 16(1):256. PubMed ID: 34082789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.